<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.0?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Radiol Bras</journal-id><journal-id journal-id-type="iso-abbrev">Radiol Bras</journal-id><journal-id journal-id-type="publisher-id">rb</journal-id><journal-title-group><journal-title>Radiologia Brasileira</journal-title></journal-title-group><issn pub-type="ppub">0100-3984</issn><issn pub-type="epub">1678-7099</issn><publisher><publisher-name>Publica&#x000e7;&#x000e3;o do Col&#x000e9;gio Brasileiro de Radiologia e Diagn&#x000f3;stico por Imagem</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7458567</article-id><article-id pub-id-type="doi">10.1590/0100-3984.2020.0030</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title>Thoracic tomographic manifestations in symptomatic respiratory patients with COVID-19</article-title><trans-title-group xml:lang="pt"><trans-title>Altera&#x000e7;&#x000f5;es tomogr&#x000e1;ficas tor&#x000e1;cicas em pacientes sintom&#x000e1;ticos respirat&#x000f3;rios com a COVID-19</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-5195-9818</contrib-id><name><surname>de Farias</surname><given-names>Lucas de P&#x000e1;dua Gomes</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="c1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-0526-5775</contrib-id><name><surname>Strabelli</surname><given-names>Daniel Giunchetti</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-0233-0041</contrib-id><name><surname>Fonseca</surname><given-names>Eduardo Kaiser Ururahy Nunes</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-7270-2664</contrib-id><name><surname>Loureiro</surname><given-names>Bruna Melo Coelho</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-7131-6614</contrib-id><name><surname>Nomura</surname><given-names>Cesar Higa</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-9424-9776</contrib-id><name><surname>Sawamura</surname><given-names>M&#x000e1;rcio Valente Yamada</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><aff id="aff1">
<label>1</label> Instituto de Radiologia do Hospital das Cl&#x000ed;nicas da Faculdade de Medicina da Universidade de S&#x000e3;o Paulo (InRad/HC-FMUSP), S&#x000e3;o Paulo, SP, Brazil.</aff></contrib-group><author-notes><corresp id="c1">Correspondence: Dr. Lucas de P&#x000e1;dua Gomes de Farias. Instituto de Radiologia - HC-FMUSP. Rua Doutor Ov&#x000ed;dio Pires de Campos, 75, Cerqueira C&#x000e9;sar. S&#x000e3;o Paulo, SP, Brazil, 05403-010. Email: <email>lucas.padua@hc.fm.usp.br</email>.</corresp></author-notes><pub-date pub-type="epub-ppub"><season>Jul-Aug</season><year>2020</year></pub-date><!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' --><pub-date pub-type="ppub"><season>Jul-Aug</season><year>2020</year></pub-date><volume>53</volume><issue>4</issue><fpage>255</fpage><lpage>261</lpage><history><date date-type="received"><day>31</day><month>3</month><year>2020</year></date><date date-type="accepted"><day>23</day><month>4</month><year>2020</year></date></history><permissions><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>China was the epicenter for the novel coronavirus disease (COVID-19), which quickly spread to other Asian countries and later to Western countries; subsequently, COVID-19 was categorized as a pandemic by the World Health Organization. Diagnosis primarily depends on viral detection in respiratory samples; however, available kits are limited, lack high sensitivity, and have a long turnaround time for providing results. In this scenario, computed tomography has emerged as an efficient and available high-sensitivity method, allowing radiologists to readily recognize findings related to COVID-19. The objective of this article is to demonstrate the main tomographic findings in symptomatic respiratory patients with COVID-19 to assist medical professionals during this critical moment.</p></abstract><trans-abstract xml:lang="pt"><p>A doen&#x000e7;a pelo novo coronav&#x000ed;rus (COVID-19) teve epicentro na China e rapidamente se espalhou pelos demais pa&#x000ed;ses asi&#x000e1;ticos e, posteriormente, para os pa&#x000ed;ses ocidentais, sendo definida como pandemia pela Organiza&#x000e7;&#x000e3;o Mundial da Sa&#x000fa;de. O diagn&#x000f3;stico da COVID-19 &#x000e9; primariamente dependente da pesquisa do v&#x000ed;rus nas vias a&#x000e9;reas superiores, mas os kits para sua confirma&#x000e7;&#x000e3;o ainda s&#x000e3;o limitados, n&#x000e3;o apresentam sensibilidade elevada e os resultados s&#x000e3;o demorados. Nesse cen&#x000e1;rio, a tomografia computadorizada surge como m&#x000e9;todo eficiente e dispon&#x000ed;vel e com alta sensibilidade, cabendo a n&#x000f3;s radiologistas reconhecer prontamente os achados relacionados a essa doen&#x000e7;a. O objetivo deste artigo &#x000e9; demonstrar os principais achados tomogr&#x000e1;ficos de t&#x000f3;rax em pacientes sintom&#x000e1;ticos respirat&#x000f3;rios infectados pela COVID-19, de modo a auxiliar os colegas nesse momento cr&#x000ed;tico.</p></trans-abstract><kwd-group><kwd>Coronavirus</kwd><kwd>COVID-19</kwd><kwd>Multislice computed tomography</kwd></kwd-group><kwd-group xml:lang="pt"><kwd>Coronav&#x000ed;rus</kwd><kwd>COVID-19</kwd><kwd>Tomografia computadorizada de multidetectores</kwd></kwd-group></article-meta></front><body><sec sec-type="intro"><title>INTRODUCTION</title><p>Initially, the respiratory infection caused by the novel coronavirus strain SARS-CoV-2, which was first detected in the city of Wuhan (Hubei province, China) in December 2019, was reported as a &#x0201c;pneumonia of unknown etiology&#x0201d;. Since then, it has been named coronavirus disease 2019 (COVID-19) and has rapidly spread worldwide. On March 11, 2020, the World Health Organization declared COVID-19 as a pandemic<sup>(<xref rid="r1" ref-type="bibr">1</xref>,<xref rid="r2" ref-type="bibr">2</xref>)</sup>.</p><p>Reportedly, the tomographic findings of pneumonia caused by COVID-19 are nonspecific and similar to those induced by other viral infections, such as influenza, COVID- 19 triggers pneumonia, drug-induced pneumonitis, and connective tissue diseases<sup>(<xref rid="r3" ref-type="bibr">3</xref>)</sup>. Computed tomography (CT), although recognized as an extremely sensitive method, has not been indicated as the first diagnostic approach by several radiology societies, restricting its utility for specific cases such as hospitalized and symptomatic patients or in specific clinical situations<sup>(<xref rid="r3" ref-type="bibr">3</xref>-<xref rid="r6" ref-type="bibr">6</xref>)</sup>. The reference diagnosis is based on reverse transcription polymerase chain reaction (RT-PCR) and a dissociation between laboratory and tomographic findings may be present even in initially symptomatic patients<sup>(<xref rid="r3" ref-type="bibr">3</xref>,<xref rid="r7" ref-type="bibr">7</xref>,<xref rid="r8" ref-type="bibr">8</xref>)</sup>.</p><p>Chest radiography has limited efficiency due to its low sensitivity and specificity, demonstrating normal or ambiguous findings in most initial cases (<xref ref-type="fig" rid="f1">Figure 1</xref>); as such, clinicians and radiologists need to be aware of these limitations<sup>(<xref rid="r4" ref-type="bibr">4</xref>,<xref rid="r9" ref-type="bibr">9</xref>)</sup>. However, it can be used at bedside and in field hospitals. In contrast, ultrasonography can be used to monitor patients, especially those in intensive care units, as it can identify peripheral changes in the lung, the region most affected by the virus<sup>(<xref rid="r10" ref-type="bibr">10</xref>)</sup>.</p><p>
<fig id="f1" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Male patient, 35 years old. Posteroanterior chest radiography (<bold>A</bold>) showing no pulmonary changes. MDCT (<bold>B</bold>) on the same day shows opacities with ground-glass attenuation in the lower lobes. Positive RT-PCR for SARS-CoV-2.</p></caption><graphic xlink:href="rb-53-04-0255-g01"/></fig>
</p><p>The objective of this study was to present the most significant imaging results obtained from symptomatic respiratory patients with COVID-19 using a multidetector CT (MDCT). These findings were described according to the Brazilian consensus on the terminology of key descriptors and standards<sup>(<xref rid="r11" ref-type="bibr">11</xref>)</sup>.</p></sec><sec><title>PULMONARY MANIFESTATIONS</title><p>Parenchymal changes induced by the novel coronavirus are possibly related to its affinity for the angiotensin-converting enzyme 2<sup>(<xref rid="r12" ref-type="bibr">12</xref>)</sup>, which is highly expressed in the lungs and heart, allowing the virus to invade alveolar epithelial cells and resulting in cell damage and local inflammatory responses that lead to respiratory symptoms<sup>(<xref rid="r13" ref-type="bibr">13</xref>)</sup>. Postmortem histopathological examinations have demonstrated diffuse alveolar damage with fibromyxoid exudates, characterized by pulmonary edema with hyaline membrane-formation and pneumocyte desquamation, which indicate an early phase of acute respiratory distress, suggesting that this is the pathological process underlying the tomographic findings of alveolar and interstitial damage and parenchymal changes<sup>(<xref rid="r14" ref-type="bibr">14</xref>)</sup>.</p><p>Initially, CT scans may fail to detect changes or indicate only small areas of ground-glass opacity, which are sometimes isolated. Over time, the number and extent of pulmonary findings increase, mainly with consolidations and crazy-paving areas. These findings usually peak around the 10th day and slowly regress. In the late stages, linear opacities are commonly observed, although ground-glass opacities and consolidations may persist<sup>(<xref rid="r15" ref-type="bibr">15</xref>)</sup>.</p><sec><title>Ground-glass pattern</title><p>A ground-glass pattern is defined as an increased density of the pulmonary parenchyma that does not obscure the bronchial and vascular structures within the area affected by the pathological process. Additionally, it may be related to interstitial thickening, partial air space filling, partial alveoli collapse, increased capillary blood volume, or an association with any of these factors<sup>(<xref rid="r11" ref-type="bibr">11</xref>)</sup>. Ground-glass opacities in patients with COVID-19 pneumonia tend to be multi- and bilateral, predominantly peripheral, mainly posterior and with a slight predominance in the middle and lower pulmonary fields (<xref ref-type="fig" rid="f1">Figures 1</xref> and <xref ref-type="fig" rid="f2">2</xref>), indicated as the most frequent initial signs in most cases<sup>(<xref rid="r7" ref-type="bibr">7</xref>,<xref rid="r15" ref-type="bibr">15</xref>-<xref rid="r17" ref-type="bibr">17</xref>)</sup>. Although literature describes a variable incidence of ground-glass opacities, it is considered an usual finding, ranging between 86% and 100% in some studies<sup>(<xref rid="r15" ref-type="bibr">15</xref>,<xref rid="r18" ref-type="bibr">18</xref>,<xref rid="r19" ref-type="bibr">19</xref>)</sup>.</p><p>
<fig id="f2" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Male patient, 48 years old. MDCT shows ground-glass opacities and diffuse consolidation foci in the upper (<bold>A</bold>), middle (<bold>B</bold>), and lower (<bold>C</bold>) lung fields with predominantly peripheral distribution in the posterior regions. Positive RTPCR for SARS-CoV-2.</p></caption><graphic xlink:href="rb-53-04-0255-g02"/></fig>
</p></sec><sec><title>Consolidation</title><p>Consolidation refers to the replacement of air in the alveolar space by cells, tissues, or pathological fluids, obscuring the local vessels and bronchial margins, sometimes forming air bronchograms<sup>(<xref rid="r11" ref-type="bibr">11</xref>)</sup>. In COVID-19, consolidations are often associated with ground-glass opacities with a similar distribution pattern<sup>(<xref rid="r16" ref-type="bibr">16</xref>,<xref rid="r17" ref-type="bibr">17</xref>,<xref rid="r20" ref-type="bibr">20</xref>)</sup> (<xref ref-type="fig" rid="f2">Figure 2</xref>). Consolidations tend to appear later, indicating the organized pathophysiological disease process, and are frequently observed after the onset of reticular opacities and crazy-paving patterns<sup>(<xref rid="r15" ref-type="bibr">15</xref>,<xref rid="r17" ref-type="bibr">17</xref>)</sup>. They are found to occur in 31.8% to 41% of cases<sup>(<xref rid="r16" ref-type="bibr">16</xref>,<xref rid="r17" ref-type="bibr">17</xref>)</sup>; however, this incidence varies, especially when evaluated together with ground-glass and/or reticular opacities<sup>(<xref rid="r15" ref-type="bibr">15</xref>,<xref rid="r18" ref-type="bibr">18</xref>)</sup>.</p></sec><sec><title>Reticular pattern</title><p>Usually associated with interstitial diseases, reticular patterns demonstrate the thickening of interlobular and intralobular septa, presenting as linear opacities on tomography<sup>(<xref rid="r11" ref-type="bibr">11</xref>)</sup>. This is not a common finding in the initial presentations of COVID-19 and is observed in less than 22% cases<sup>(<xref rid="r15" ref-type="bibr">15</xref>,<xref rid="r19" ref-type="bibr">19</xref>)</sup>, usually in later stages of the disease and preferentially in the periphery of the lungs<sup>(<xref rid="r7" ref-type="bibr">7</xref>,<xref rid="r17" ref-type="bibr">17</xref>,<xref rid="r20" ref-type="bibr">20</xref>)</sup> (<xref ref-type="fig" rid="f3">Figure 3A</xref>). Conversely, 20% of patients with pneumonia caused by the novel coronavirus have been reported to exhibit subpleural lines, which are nonspecific indicators of atelectasis, edema, fibrosis, or inflammation, characterized by subpleural curvilinear opacities parallel to its surface<sup>(<xref rid="r11" ref-type="bibr">11</xref>,<xref rid="r18" ref-type="bibr">18</xref>)</sup> (<xref ref-type="fig" rid="f3">Figure 3B</xref>).</p><p>
<fig id="f3" orientation="portrait" position="float"><label>Figure 3</label><caption><p>Female patients, 51 (<bold>A</bold>) and 68 years old (<bold>B</bold>). MDCT shows reticular opacities (arrows) in the anterior segment of the right upper lobe and bilateral subpleural curvilinear lines (arrowheads) in the lower lobes. Additionally, other multifocal opacities with ground-glass attenuation are present. Positive RT-PCR for SARS-CoV-2 in both patients.</p></caption><graphic xlink:href="rb-53-04-0255-g03"/></fig>
</p></sec><sec><title>Crazy-paving</title><p>Crazy-paving indicates the overlapping of ground-glass opacities and thickening of interlobular and intralobular septa, with a well-defined interface between adjacent normal lung parenchyma, indicating alveolar and interstitial involvement<sup>(<xref rid="r11" ref-type="bibr">11</xref>)</sup>. Tomographic identification suggests disease progression or even a peak stage, observed in 53% of cases<sup>(<xref rid="r15" ref-type="bibr">15</xref>)</sup>; however, it is not common during resolution phases<sup>(<xref rid="r15" ref-type="bibr">15</xref>,<xref rid="r17" ref-type="bibr">17</xref>)</sup> (<xref ref-type="fig" rid="f4">Figure 4</xref>).</p><p>
<fig id="f4" orientation="portrait" position="float"><label>Figure 4</label><caption><p>Male patient, 59 years old. MDCT shows ground-glass opacity in the right lung associated with interlobular and intralobular septal thickening, characterized by the crazy-paving pattern (arrowheads) and some consolidation foci (arrows). Positive RT-PCR for SARS-CoV-2.</p></caption><graphic xlink:href="rb-53-04-0255-g04"/></fig>
</p></sec><sec><title>Reversed halo sign</title><p>This indicates a ground-glass opacity that is partially or completely surrounded by a consolidation ring<sup>(<xref rid="r11" ref-type="bibr">11</xref>)</sup>, which may represent stages of disease progression with a pattern of organizing pneumonia<sup>(<xref rid="r9" ref-type="bibr">9</xref>,<xref rid="r17" ref-type="bibr">17</xref>,<xref rid="r21" ref-type="bibr">21</xref>)</sup>; it has been observed in up to 8% of cases<sup>(<xref rid="r19" ref-type="bibr">19</xref>)</sup> (<xref ref-type="fig" rid="f5">Figure 5</xref>).</p><p>
<fig id="f5" orientation="portrait" position="float"><label>Figure 5</label><caption><p>Male patient, 56 years old. MDCT shows ground-glass attenuation opacities, partially or surrounded by a consolidation ring, characterized by the reversed halo sign (arrowheads) in both lungs. Positive RT-PCR for SARS-CoV-2.</p></caption><graphic xlink:href="rb-53-04-0255-g05"/></fig>
</p></sec><sec><title>Nodule</title><p>Nodules are defined as rounded focal opacities measuring less than 3 cm, with or without calcifications that can be solid, partially solid, or only presenting ground-glass attenuation<sup>(<xref rid="r11" ref-type="bibr">11</xref>)</sup>. These can be observed in viral pneumonia and have been reported in 3-13% of COVID-19 pneumonia cases<sup>(<xref rid="r8" ref-type="bibr">8</xref>,<xref rid="r18" ref-type="bibr">18</xref>,<xref rid="r22" ref-type="bibr">22</xref>)</sup>, with some demonstrating a surrounding ground-glass zone that forms the halo sign<sup>(<xref rid="r8" ref-type="bibr">8</xref>,<xref rid="r23" ref-type="bibr">23</xref>,<xref rid="r24" ref-type="bibr">24</xref>)</sup>.</p></sec><sec><title>Parenchymal band</title><p>The parenchymal band is described as a peripheral linear opacity, perpendicular or oblique to the pleural surface, which may be thickened or retracted at the contact site. Furthermore, it is usually associated with pleural parenchymal fibrosis<sup>(<xref rid="r11" ref-type="bibr">11</xref>)</sup> and occurs more frequently during advanced stages of the disease compared to initial stages<sup>(<xref rid="r7" ref-type="bibr">7</xref>)</sup> (<xref ref-type="fig" rid="f6">Figure 6</xref>). Although some studies suggest that fibrotic streaks may appear during the resolution of parenchymal aggression, with inflammatory cells replaced by fibrous tissue, other studies report that it is a sign of poor prognosis, with progression to fibrous interstitial disease<sup>(<xref rid="r8" ref-type="bibr">8</xref>,<xref rid="r15" ref-type="bibr">15</xref>,<xref rid="r22" ref-type="bibr">22</xref>)</sup>.</p><p>
<fig id="f6" orientation="portrait" position="float"><label>Figure 6</label><caption><p>Male patient, 70 years old. MDCT shows parenchymal bands/fibroatelectatic band opacities on the pulmonary periphery. Additionally, other opacities with ground-glass attenuation are observed. Positive RT-PCR for SARS-CoV-2.</p></caption><graphic xlink:href="rb-53-04-0255-g06"/></fig>
</p></sec><sec><title>Pseudo-cavity</title><p>The pseudo-cavity represents an area less than 1 cm in diameter and has a low attenuation coefficient inside pulmonary nodules/masses or consolidations<sup>(<xref rid="r11" ref-type="bibr">11</xref>)</sup>. In cases of pneumonia caused by the novel coronavirus, pseudo-cavity may represent a pathological airspace dilation, cross-sectional bronchiectasis, or a consolidation area during the resorption process<sup>(<xref rid="r21" ref-type="bibr">21</xref>)</sup> (<xref ref-type="fig" rid="f7">Figure 7</xref>). It is important to establish a differential diagnosis with cavitary lesions (cavities/excavations), which are atypical and infrequent injuries in COVID-19 pneumonia. Furthermore, associated complications such as overlapping secondary infections and alternative diagnoses should be considered<sup>(<xref rid="r3" ref-type="bibr">3</xref>,<xref rid="r16" ref-type="bibr">16</xref>,<xref rid="r17" ref-type="bibr">17</xref>,<xref rid="r25" ref-type="bibr">25</xref>)</sup>.</p><p>
<fig id="f7" orientation="portrait" position="float"><label>Figure 7</label><caption><p>Male patient, 41 years old. MDCT shows pseudo-cavity associated with consolidation and ground-glass opacity on the right lower lobe (arrowhead). Positive RT-PCR for SARS-CoV-2.</p></caption><graphic xlink:href="rb-53-04-0255-g07"/></fig>
</p></sec><sec><title>Vascular ectasia</title><p>Vascular ectasia is usually represented by the dilation of pulmonary vessels inside or adjacent to a lesion due to damage and capillary edema caused by the activity of local inflammatory factors<sup>(<xref rid="r18" ref-type="bibr">18</xref>)</sup> (<xref ref-type="fig" rid="f8">Figure 8</xref>).</p><p>
<fig id="f8" orientation="portrait" position="float"><label>Figure 8</label><caption><p>Male patient, 44 years old. Axial MDCT image with maximum intensity projection reconstruction shows extensive peripheral opacity with groundglass attenuation and some ectatic vessels inside (arrowhead). Positive RTPCR for SARS-CoV-2.</p></caption><graphic xlink:href="rb-53-04-0255-g08"/></fig>
</p></sec></sec><sec><title>PLEURAL MANIFESTATIONS</title><p>Pleural changes are less frequent<sup>(<xref rid="r17" ref-type="bibr">17</xref>,<xref rid="r25" ref-type="bibr">25</xref>)</sup>, especially during the initial stages. However, pleural thickening, effusion (<xref ref-type="fig" rid="f9">Figure 9</xref>), and retraction can occur during the disease<sup>(<xref rid="r16" ref-type="bibr">16</xref>,<xref rid="r20" ref-type="bibr">20</xref>)</sup>. The presence of pleural effusion suggests overlapping infection or alternative diagnoses<sup>(<xref rid="r8" ref-type="bibr">8</xref>)</sup>.</p><p>
<fig id="f9" orientation="portrait" position="float"><label>Figure 9</label><caption><p>Male patient, 69 years old. MDCT shows diffuse ground-glass opacity in both lungs and consolidation foci associated with a minor bilateral pleural effusion, indicating restrictive atelectasis of the adjacent lung parenchyma. Positive RT-PCR for SARS-CoV-2.</p></caption><graphic xlink:href="rb-53-04-0255-g09"/></fig>
</p></sec><sec><title>AIRWAY MANIFESTATIONS</title><p>Airway changes, including bronchial wall thickening and centrilobular micronodules and with tree-in-bud, remain infrequent. The most observed sign is an air bronchogram (<xref ref-type="fig" rid="f10">Figure 10</xref>), identified between ground-glass opacities or consolidations. Peribronchial inflammatory changes, represented by parietal or peribronchovascular interstitial thickening, can retract the walls with consequent distortion and ectasia<sup>(<xref rid="r20" ref-type="bibr">20</xref>)</sup> (<xref ref-type="fig" rid="f10">Figure 10</xref>).</p><p>
<fig id="f10" orientation="portrait" position="float"><label>Figure 10</label><caption><p>Female patient, 76 years old. MDCT shows air bronchogram between opacity with ground-glass attenuation and some consolidation foci associated with bronchial wall thickening and distortion (arrowhead). Positive RT-PCR for SARS-CoV-2.</p></caption><graphic xlink:href="rb-53-04-0255-g10"/></fig>
</p></sec><sec><title>CARDIOVASCULAR AND MEDIASTINAL MANIFESTATIONS</title><p>Cardiovascular complications including myocarditis, acute myocardial infarction, and exacerbation of heart failure are associated with comorbidities and other complications; such complications have been well recognized in historical viral epidemics, such as influenza and previous coronavirus outbreaks<sup>(<xref rid="r13" ref-type="bibr">13</xref>,<xref rid="r26" ref-type="bibr">26</xref>)</sup>, due to the mechanism of angiotensin-converting enzyme 2 and the intense cytokine production by T helper lymphocytes types 1 and 2<sup>(<xref rid="r13" ref-type="bibr">13</xref>)</sup>. The consequences of cardiac symptoms can be intensified by acute respiratory distress syndrome, as well as by mechanical ventilation with hemodynamic implications.</p><p>In cases of limited availability or use of echocardiogram and/or cardiac magnetic resonance, contrasted-enhanced chest CT, even if not coupled with the electrocardiogram, can provide information regarding the diameter of cardiac chambers as well as pericardial changes. The dimensions of the cardiac chambers can be estimated using the evaluation proposed by Hota et al.<sup>(<xref rid="r27" ref-type="bibr">27</xref>)</sup> (<xref ref-type="fig" rid="f11">Figure 11</xref>). The pericardial effusion volume can be estimated using the evaluation proposed by Ivens et al.<sup>(<xref rid="r28" ref-type="bibr">28</xref>)</sup> (<xref ref-type="fig" rid="f11">Figure 11</xref>), which considers a normal pericardial thickness of up to 2 mm.</p><p>
<fig id="f11" orientation="portrait" position="float"><label>Figure 11</label><caption><p>Illustrative scheme to measure the cardiac chambers and estimate the volume of pericardial effusion/thickening in chest tomography not coupled to an electrocardiogram. The left atrium (LA) must be measured in the anteroposterior diameter while the other cardiac chambers must be measured in the transverse diameter<sup>(<xref rid="r27" ref-type="bibr">27</xref>,<xref rid="r28" ref-type="bibr">28</xref>)</sup>.</p></caption><graphic xlink:href="rb-53-04-0255-g11"/></fig>
</p><p>Pericardial effusion and mediastinal lymph node enlargement (diameter greater than 1 cm in its shortest axis) are uncommon findings during the initial stages of COVID- 19<sup>(<xref rid="r15" ref-type="bibr">15</xref>,<xref rid="r17" ref-type="bibr">17</xref>,<xref rid="r25" ref-type="bibr">25</xref>)</sup>; however, when present, they both suggest a more severe disease state<sup>(<xref rid="r29" ref-type="bibr">29</xref>)</sup>.</p></sec><sec sec-type="conclusions"><title>CONCLUSION</title><p>Recent studies have suggested that chest CT has greater sensitivity but low specificity when compared to RT-PCR for the diagnosis of COVID-19<sup>(<xref rid="r1" ref-type="bibr">1</xref>,<xref rid="r8" ref-type="bibr">8</xref>,<xref rid="r30" ref-type="bibr">30</xref>,<xref rid="r31" ref-type="bibr">31</xref>)</sup>; however, a diagnostic confirmation with the viral test is necessary for etiological diagnosis, even with typical radiological findings<sup>(<xref rid="r4" ref-type="bibr">4</xref>)</sup>. The use of CT to evaluate patients with suspected COVID-19 has been increasingly considered, although most professional societies do not recommend its use as a screening method<sup>(<xref rid="r3" ref-type="bibr">3</xref>-<xref rid="r6" ref-type="bibr">6</xref>)</sup>. The predominant typical radiological findings include peripheral and bilateral multilobe and bilateral ground-glass opacities, with or without septal consolidation, round opacities with ground-glass attenuation with or without consolidation foci or septal thickening, or the reverted halo sign (or other findings of organizing pneumonia). When these imaging patterns are not present, chest CT scans can still be categorized as indeterminate, atypical, or negative for pneumonia, highlighting that some tests demonstrate no radiological changes during the earlier stages of the disease<sup>(<xref rid="r3" ref-type="bibr">3</xref>)</sup>.</p></sec></body><back><ref-list><title>REFERENCES</title><ref id="r1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>N</given-names></name><name><surname>Zhang</surname><given-names>D</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><etal/></person-group><article-title>A novel coronavirus from patients with pneumonia in China, 2019</article-title><source>N Engl J Med</source><year>2020</year><volume>382</volume><fpage>727</fpage><lpage>733</lpage><pub-id pub-id-type="pmid">31978945</pub-id></element-citation></ref><ref id="r2"><label>2</label><element-citation publication-type="webpage"><person-group person-group-type="author"><collab>World Health Organization</collab></person-group><source>WHO Director-General's opening remarks at the media briefing on COVID-19 - 11 March 2020</source><date-in-citation content-type="updated">2020 Mar 11</date-in-citation><date-in-citation content-type="access-date">2020 Mar 23</date-in-citation><comment>Available from: <ext-link ext-link-type="uri" xlink:href="https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020">https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020</ext-link></comment></element-citation></ref><ref id="r3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simpson</surname><given-names>S</given-names></name><name><surname>Kay</surname><given-names>FU</given-names></name><name><surname>Abbara</surname><given-names>S</given-names></name><etal/></person-group><article-title>Radiological Society of North America Expert Consensus Statement on Reporting Chest CT Findings Related to COVID-19. Endorsed by the Society of Thoracic Radiology, the American College of Radiology, and RSNA</article-title><source>Radiology: Cardiothoracic Imaging</source><year>2020</year><volume>2</volume><issue>2</issue></element-citation></ref><ref id="r4"><label>4</label><element-citation publication-type="webpage"><person-group person-group-type="author"><collab>American College of Radiology</collab></person-group><source>ACR Recommendations for the use of chest radiography and computed tomography (CT) for suspected COVID-19 infection</source><date-in-citation content-type="updated">2020 Mar 22</date-in-citation><date-in-citation content-type="access-date">2020 Mar 23</date-in-citation><comment>Available from: <ext-link ext-link-type="uri" xlink:href="https://www.acr.org/Advocacy-and-Economics/ACR-Position-Statements/Recommendations-for-Chest-Radiography-and-CT-for-Suspected-COVID19-Infection">https://www.acr.org/Advocacy-and-Economics/ACR-Position-Statements/Recommendations-for-Chest-Radiography-and-CT-for-Suspected-COVID19-Infection</ext-link></comment></element-citation></ref><ref id="r5"><label>5</label><element-citation publication-type="webpage"><person-group person-group-type="author"><collab>Col&#x000e9;gio Brasileiro de Radiologia e Diagn&#x000f3;stico por Imagem</collab></person-group><source>Recomenda&#x000e7;&#x000f5;es de uso de m&#x000e9;todos de imagem para pacientes suspeitos de infec&#x000e7;&#x000e3;o pelo COVID-19</source><date-in-citation content-type="access-date">2020 Mar 23</date-in-citation><comment>Available from: <ext-link ext-link-type="uri" xlink:href="https://cbr.org.br/wp-content/uploads/2020/03/CBR_Recomenda&#x000e7;&#x000f5;es-de-uso-de-m&#x000e9;todos-de-imagem_16-03-2020.pdf">https://cbr.org.br/wp-content/uploads/2020/03/CBR_Recomenda&#x000e7;&#x000f5;es-de-uso-de-m&#x000e9;todos-de-imagem_16-03-2020.pdf</ext-link></comment></element-citation></ref><ref id="r6"><label>6</label><element-citation publication-type="webpage"><person-group person-group-type="author"><collab>Society of Thoracic Radiology</collab></person-group><source>STR/ASER COVID-19 Position Statement March 11, 2020</source><date-in-citation content-type="updated">2020 Mar 11</date-in-citation><date-in-citation content-type="access-date">2020 Mar 23</date-in-citation><comment>Available from: <ext-link ext-link-type="uri" xlink:href="https://thoracicrad.org">https://thoracicrad.org</ext-link></comment></element-citation></ref><ref id="r7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Araujo Filho</surname><given-names>JAB</given-names></name><name><surname>Sawamura</surname><given-names>MVY</given-names></name><name><surname>Costa</surname><given-names>AN</given-names></name><etal/></person-group><article-title>Pneumonia por COVID-19: qual o papel da imagem no diagn&#x000f3;stico?</article-title><source>J Bras Pneumol.</source><year>2020</year><volume>46</volume><issue>2</issue><comment>[Epub Mar 27, 2020]</comment></element-citation></ref><ref id="r8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanne</surname><given-names>JP</given-names></name><name><surname>Little</surname><given-names>BP</given-names></name><name><surname>Chung</surname><given-names>JH</given-names></name><etal/></person-group><article-title>Essentials for radiologists on COVID-19: an update-Radiology Scientific Expert Panel</article-title><source>Radiology</source><year>2020</year><elocation-id>200527</elocation-id><comment>[Epub ahead of print]</comment></element-citation></ref><ref id="r9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoon</surname><given-names>SH</given-names></name><name><surname>Lee</surname><given-names>KH</given-names></name><name><surname>Kim</surname><given-names>JY</given-names></name><etal/></person-group><article-title>Chest radiographic and CT findings of the 2019 novel coronavirus disease (COVID-19): analysis of nine patients treated in Korea</article-title><source>Korean J Radiol</source><year>2020</year><volume>21</volume><fpage>494</fpage><lpage>500</lpage><pub-id pub-id-type="pmid">32100485</pub-id></element-citation></ref><ref id="r10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soldati</surname><given-names>G</given-names></name><name><surname>Smargiassi</surname><given-names>A</given-names></name><name><surname>Inchingolo</surname><given-names>R</given-names></name><etal/></person-group><article-title>Is there a role for lung ultrasound during the COVID-19 pandemic?</article-title><source>J Ultrasound Med.</source><year>2020</year><comment>[Epun ahead of print]</comment></element-citation></ref><ref id="r11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silva</surname><given-names>CIS</given-names></name><name><surname>Marchiori</surname><given-names>E</given-names></name><name><surname>Souza J&#x000fa;nior</surname><given-names>AS</given-names></name><etal/></person-group><article-title>Consenso brasileiro ilustrado sobre a terminologia dos descritores e padr&#x000f5;es fundamentais da TC de t&#x000f3;rax</article-title><source>J Bras Pneumol</source><year>2010</year><volume>36</volume><fpage>99</fpage><lpage>123</lpage><pub-id pub-id-type="pmid">20209314</pub-id></element-citation></ref><ref id="r12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>X</given-names></name><name><surname>Chen</surname><given-names>P</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><etal/></person-group><article-title>Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission</article-title><source>Sci China Life Sci</source><year>2020</year><volume>63</volume><fpage>457</fpage><lpage>460</lpage><pub-id pub-id-type="pmid">32009228</pub-id></element-citation></ref><ref id="r13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>YY</given-names></name><name><surname>Ma</surname><given-names>YT</given-names></name><name><surname>Zhang</surname><given-names>JY</given-names></name><etal/></person-group><article-title>COVID-19 and the cardiovascular system</article-title><source>Nat Rev Cardiol</source><year>2020</year><volume>17</volume><fpage>259</fpage><lpage>260</lpage><pub-id pub-id-type="pmid">32139904</pub-id></element-citation></ref><ref id="r14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>Z</given-names></name><name><surname>Shi</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Pathological findings of COVID-19 associated with acute respiratory distress syndrome</article-title><source>Lancet Respir Med</source><year>2020</year><volume>8</volume><fpage>420</fpage><lpage>422</lpage><pub-id pub-id-type="pmid">32085846</pub-id></element-citation></ref><ref id="r15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pan</surname><given-names>F</given-names></name><name><surname>Ye</surname><given-names>T</given-names></name><name><surname>Sun</surname><given-names>P</given-names></name><etal/></person-group><article-title>Time course of lung changes on chest CT during recovery from 2019 novel coronavirus (COVID-19) pneumonia</article-title><source>Radiology</source><year>2020</year><elocation-id>200370</elocation-id><comment>[Epub ahead of print]</comment></element-citation></ref><ref id="r16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salehi</surname><given-names>S</given-names></name><name><surname>Abedi</surname><given-names>A</given-names></name><name><surname>Balakrishnan</surname><given-names>S</given-names></name><etal/></person-group><article-title>Coronavirus disease 2019 (COVID-19): a systematic review of imaging findings in 919 patients</article-title><source>AJR Am J Roentgenol.</source><day>14</day><month>3</month><year>2020</year><fpage>1</fpage><lpage>7</lpage><comment>[Epub ahead of print]</comment></element-citation></ref><ref id="r17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bernheim</surname><given-names>A</given-names></name><name><surname>Mei</surname><given-names>X</given-names></name><name><surname>Huang</surname><given-names>M</given-names></name><etal/></person-group><article-title>Chest CT findings in coronavirus disease-19 (COVID-19): relationship to duration of infection</article-title><source>Radiology</source><year>2020</year><elocation-id>200463</elocation-id><comment>[Epub ahead of print]</comment><pub-id pub-id-type="pmid">32077789</pub-id></element-citation></ref><ref id="r18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ye</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Chest CT manifestations of new coronavirus disease 2019 (COVID-19): a pictorial review</article-title><source>Eur Radiol.</source><day>19</day><month>3</month><year>2020</year><comment>[Epub ahead of print]</comment></element-citation></ref><ref id="r19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chate</surname><given-names>RC</given-names></name><name><surname>Fonseca</surname><given-names>EKUN</given-names></name><name><surname>Passos</surname><given-names>RBD</given-names></name><etal/></person-group><article-title>Apresenta&#x000e7;&#x000e3;o tomogr&#x000e1;fica da infec&#x000e7;&#x000e3;o pulmonar na COVID-19: experi&#x000ea;ncia brasileira inicial</article-title><source>J Bras Pneumol.</source><year>2020</year><volume>46</volume><issue>2</issue><comment>[Epub Apr 09, 2020]</comment></element-citation></ref><ref id="r20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Zhu</surname><given-names>T</given-names></name><etal/></person-group><article-title>CT features of coronavirus disease 2019 (COVID-19) pneumonia in 62 patients in Wuhan, China</article-title><source>AJR Am J Roentgenol.</source><day>05</day><month>3</month><year>2020</year><fpage>1</fpage><lpage>8</lpage><comment>[Epub ahead of print]</comment></element-citation></ref><ref id="r21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farias</surname><given-names>LPG</given-names></name><name><surname>Strabelli</surname><given-names>DG</given-names></name><name><surname>Sawamura</surname><given-names>MVY</given-names></name></person-group><article-title>Pneumonia por COVID-19 e o sinal do halo invertido</article-title><source>J Bras Pneumol.</source><year>2020</year><volume>46</volume><issue>2</issue><comment>[Epub Apr 22, 2020]</comment></element-citation></ref><ref id="r22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pan</surname><given-names>Y</given-names></name><name><surname>Guan</surname><given-names>H</given-names></name><name><surname>Zhou</surname><given-names>S</given-names></name><etal/></person-group><article-title>Initial CT findings and temporal changes in patients with the novel coronavirus pneumonia (2019-nCoV): a study of 63 patients in Wuhan, China</article-title><source>Eur Radiol.</source><day>13</day><month>2</month><year>2020</year><comment>[Epub ahead of print]</comment></element-citation></ref><ref id="r23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Zeng</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>B</given-names></name><etal/></person-group><article-title>COVID-19 infection presenting with CT halo sign</article-title><source>Radiology: Cardiothoracic Imaging</source><day>12</day><month>2</month><year>2020</year><volume>2</volume><issue>1</issue></element-citation></ref><ref id="r24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farias</surname><given-names>LP</given-names></name><name><surname>Pereira</surname><given-names>HA</given-names></name><name><surname>Anastacio</surname><given-names>EP</given-names></name><etal/></person-group><article-title>O sinal do halo como apresenta&#x000e7;&#x000e3;o tomogr&#x000e1;fica pulmonar na COVID-19</article-title><source>Einstein (S&#x000e3;o Paulo)</source><year>2020</year><volume>18</volume><elocation-id>eAI5742</elocation-id><pub-id pub-id-type="pmid">32374802</pub-id></element-citation></ref><ref id="r25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ng</surname><given-names>MY</given-names></name><name><surname>Lee</surname><given-names>EYP</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><etal/></person-group><article-title>Imaging profile of the COVID-19 infection: radiologic findings and literature review</article-title><source>Radiology: Cardiothoracic Imaging</source><day>13</day><month>2</month><year>2020</year><volume>2</volume><issue>1</issue></element-citation></ref><ref id="r26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xiong</surname><given-names>TY</given-names></name><name><surname>Redwood</surname><given-names>S</given-names></name><name><surname>Prendergast</surname><given-names>B</given-names></name><etal/></person-group><article-title>Coronaviruses and the cardiovascular system: acute and long-term implications</article-title><source>Eur Heart J</source><year>2020</year><elocation-id>ehaa231</elocation-id></element-citation></ref><ref id="r27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hota</surname><given-names>P</given-names></name><name><surname>Simpson</surname><given-names>S</given-names></name></person-group><article-title>Going beyond cardiomegaly: evaluation of cardiac chamber enlargement at non-electrocardiographically gated multidetector CT: current techniques, limitations, and clinical implications</article-title><source>Radiology: Cardiothoracic Imaging</source><day>25</day><month>4</month><year>2019</year><volume>1</volume><issue>1</issue></element-citation></ref><ref id="r28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ivens</surname><given-names>EL</given-names></name><name><surname>Munt</surname><given-names>BI</given-names></name><name><surname>Moss</surname><given-names>RR</given-names></name></person-group><article-title>Pericardial disease: what the general cardiologist needs to know</article-title><source>Heart</source><year>2007</year><volume>93</volume><fpage>993</fpage><lpage>1000</lpage><pub-id pub-id-type="pmid">17639117</pub-id></element-citation></ref><ref id="r29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>K</given-names></name><name><surname>Wu</surname><given-names>J</given-names></name><name><surname>Wu</surname><given-names>F</given-names></name><etal/></person-group><article-title>The clinical and chest CT features associated with severe and critical COVID-19 pneumonia</article-title><source>Invest Radiol.</source><day>29</day><month>2</month><year>2020</year><comment>[Epub ahead of print]</comment></element-citation></ref><ref id="r30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fang</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Xie</surname><given-names>J</given-names></name><etal/></person-group><article-title>Sensitivity of chest CT for COVID-19: comparison to RT-PCR</article-title><source>Radiology</source><year>2020</year><elocation-id>200432</elocation-id><comment>[Epub ahead of print]</comment></element-citation></ref><ref id="r31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ai</surname><given-names>T</given-names></name><name><surname>Yang</surname><given-names>Z</given-names></name><name><surname>Hou</surname><given-names>H</given-names></name><etal/></person-group><article-title>Correlation of chest CT and RT-PCR testing for coronavirus disease 2019 (COVID-19) in China: a report of 1014 cases</article-title><source>Radiology</source><year>2020</year><elocation-id>200642</elocation-id><comment>[Epub ahead of print]</comment></element-citation></ref></ref-list></back></article>